Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Tempero

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|April 16, 1998
Complications and technical limitations of hepatic arterial infusion catheter placement for chemotherapyT G Habbe, T C McCowan, T C Goertzen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2011
Pancreatic cancer treatment and research: an international expert panel discussionM A Tempero, J Berlin, M Ducreux, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1994
The effect of garlic extract on human metabolism of acetaminophenP R Gwilt, C L Lear, M A Tempero, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1992
Quantitation of metastatic tumor burden from human colon tumor xenografts using radiolabelled monoclonal antibody 17-A fragmentsS S Joshi, S L Mann, M A Tempero, et al.
Human Pathology|September 1, 1989
Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseasesY Takiyama, M A Tempero, H Takasaki, et al.
International Journal of Cancer|November 15, 1988
Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissueH Takasaki, M A Tempero, E Uchida, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49P K Leichner, G Akabani, D Colcher, et al.
British Journal of Cancer|July 25, 2013
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancerA H Ko, M A Tempero, Y-S Shan, et al.
Journal of Hematotherapy|April 1, 1995
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilizationA Kessinger, M R Bishop, J R Anderson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2001
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family membersF J Rutar, S C Augustine, D Colcher, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Vascular and Interventional Radiology : JVIR|April 16, 1998
Complications and technical limitations of hepatic arterial infusion catheter placement for chemotherapyT G Habbe, T C McCowan, T C Goertzen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2011
Pancreatic cancer treatment and research: an international expert panel discussionM A Tempero, J Berlin, M Ducreux, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1994
The effect of garlic extract on human metabolism of acetaminophenP R Gwilt, C L Lear, M A Tempero, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1992
Quantitation of metastatic tumor burden from human colon tumor xenografts using radiolabelled monoclonal antibody 17-A fragmentsS S Joshi, S L Mann, M A Tempero, et al.
Human Pathology|September 1, 1989
Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseasesY Takiyama, M A Tempero, H Takasaki, et al.
International Journal of Cancer|November 15, 1988
Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissueH Takasaki, M A Tempero, E Uchida, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49P K Leichner, G Akabani, D Colcher, et al.
British Journal of Cancer|July 25, 2013
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancerA H Ko, M A Tempero, Y-S Shan, et al.
Journal of Hematotherapy|April 1, 1995
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilizationA Kessinger, M R Bishop, J R Anderson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2001
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family membersF J Rutar, S C Augustine, D Colcher, et al.
Pageof 6